Abon Pharmaceuticalsllc Is A Specialty Pharmaceutical Company Based In Chestnut Ridgenyfounded In 2009The Company Specializes In Developing Complex Generics And Proprietary Productsfocusing On Both Injectable And Oral Formulationsabon Employs Scientific Methods And Modern Technology To Enhance Product Quality And Improve Patient Compliance The Company Offers Expertise In Drug Delivery Research And Product Developmentmaking It A Preferred Partner For Challenging Proprietary And Generic Productsabon Is Known For Its Rapid Development And Manufacturing Capabilitiesensuring High Quality Pharmaceutical Productsone Of Its Notable Offerings Is A Generic Version Of Carafatea Sucralfateoral Suspensionwhich Received Fda Approval In March 2024 Led By Salah Ahmedph D Abon Pharmaceuticals Employs Around 54 People And Positions Itself As A Partner For Companies Looking To Outsource Product Development And Manufacturingthe Companyae S Commitment To Innovation In The Pharmaceutical Manufacturing Industry Supports Its Mission To Improve Drug Delivery And Formulation Efficiency
